Nothing Special   »   [go: up one dir, main page]

AU2002221222A1 - Novel method and use - Google Patents

Novel method and use

Info

Publication number
AU2002221222A1
AU2002221222A1 AU2002221222A AU2122202A AU2002221222A1 AU 2002221222 A1 AU2002221222 A1 AU 2002221222A1 AU 2002221222 A AU2002221222 A AU 2002221222A AU 2122202 A AU2122202 A AU 2122202A AU 2002221222 A1 AU2002221222 A1 AU 2002221222A1
Authority
AU
Australia
Prior art keywords
novel method
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221222A
Inventor
Jerry R Colca
Alvar Gronberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004462A external-priority patent/SE0004462D0/en
Application filed by Biovitrum AB filed Critical Biovitrum AB
Publication of AU2002221222A1 publication Critical patent/AU2002221222A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002221222A 2000-12-04 2001-12-04 Novel method and use Abandoned AU2002221222A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0004462A SE0004462D0 (en) 2000-12-04 2000-12-04 Novel method and use
SE0004462 2000-12-04
US25470100P 2000-12-11 2000-12-11
US60254701 2000-12-11
PCT/SE2001/002680 WO2002045712A1 (en) 2000-12-04 2001-12-04 Novel method and use

Publications (1)

Publication Number Publication Date
AU2002221222A1 true AU2002221222A1 (en) 2002-06-18

Family

ID=26655328

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221222A Abandoned AU2002221222A1 (en) 2000-12-04 2001-12-04 Novel method and use

Country Status (2)

Country Link
AU (1) AU2002221222A1 (en)
WO (1) WO2002045712A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2500918T3 (en) 2001-12-21 2014-10-01 Human Genome Sciences, Inc. Albumin and interferon beta fusion proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539325A (en) * 1983-11-07 1985-09-03 Janssen Pharmaceutica N.V. 1-(2-Aryl-2-halo-1-ethenyl)-1H-azoles, and anticonvulsant use thereof
CA2113817A1 (en) * 1991-08-27 1993-02-04 Jerry R. Colca A method for treatment of metabolic disorders
WO2000033839A1 (en) * 1998-12-10 2000-06-15 Agouron Pharmaceuticals, Inc. Non-peptide antagonists of glp-1 receptor and methods of use
AU778393B2 (en) * 1999-05-12 2004-12-02 Ortho-Mcneil Pharmaceutical, Inc. Pyrazole carboxamides useful for the treatment of obesity and other disorders

Also Published As

Publication number Publication date
WO2002045712A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2001286419A1 (en) Endourethral device and method
AU2001252973A1 (en) Biosensor and related method
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001263028A1 (en) Stream-cipher method and apparatus
AU2001256933A1 (en) Apparatus and method
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001265052A1 (en) Package kit and method
AU2001294549A1 (en) Process and intermediates
AU2002211717A1 (en) Stresscopins and their uses
AU2001279850A1 (en) Method and arrangement for studsystem
AU2001243394A1 (en) Compounds and methods
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001233932A1 (en) Method and composition
AUPQ872300A0 (en) Compounds and methods
AU2001236718A1 (en) Bioreactor and related method
AU2001278951A1 (en) Compounds and methods
AU4432001A (en) Trityl-type compounds and their use
AU2002239775A1 (en) Chemical-library composition and method
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2002256556A1 (en) Sea-trosy and related methods
AU2002235277A1 (en) Compounds and methods